XML 22 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Net Sales $ 20,338 $ 19,318
Cost of Products Sold 10,365 9,142
Selling, General and Administrative Expense 4,950 4,895
Operating Income 5,023 5,281
Interest Expense (109) (136)
Interest Income 11 10
Other Non-operating Income/(Loss), Net 110 142
Earnings/(Loss) from Continuing Operations Before Income Taxes 5,035 5,297
Income Taxes on Continuing Operations 909 989
Net Earnings 4,126 4,308
Net Income (Loss) Attributable to Noncontrolling Interest 14 31
Net Income (Loss) Attributable to Parent $ 4,112 $ 4,277
Basic Net Earnings Per Common Share    
Basic Net Earnings/(Loss) Per Common Share [1],[2] $ 1.66 $ 1.69
Diluted Net Earnings Per Common Share    
Diluted Net Earnings/(Loss) Per Common Share [1],[2] $ 1.61 $ 1.63
Diluted Weighted Average Common Shares Outstanding 2,558.9 2,625.3
[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.